A Patient-Derived Organoid-Based Study Identified an ASO Targeting SNORD14E for Endometrial Cancer Through Reducing Aberrant FOXM1 Expression and Β-Catenin Nuclear Accumulation.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH（2023）
关键词
Endometrial cancer,Patients-derived organoid,ASO targeted therapy,Alternative splicing,2’-O-methylation modification
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要